Literature DB >> 15271865

Is the failing heart energy starved? On using chemical energy to support cardiac function.

Joanne S Ingwall1, Robert G Weiss.   

Abstract

The requirement of chemical energy in the form of ATP to support systolic and diastolic work of the heart is absolute. Because of its central role in cardiac metabolism and performance, the subject of this review on energetics in the failing heart is ATP. We briefly review the basics of myocardial ATP metabolism and describe how this changes in the failing heart. We present an analysis of what is now known about the causes and consequences of these energetic changes and conclude by commenting on unsolved problems and opportunities for future basic and clinical research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271865     DOI: 10.1161/01.RES.0000137170.41939.d9

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  236 in total

1.  Impaired ATP kinetics in failing in vivo mouse heart.

Authors:  Ashish Gupta; Vadappuram P Chacko; Michael Schär; Ashwin Akki; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 7.792

2.  Assessing mitochondrial respiration in isolated hearts using (17)O MRS.

Authors:  Ming Lu; Bharath Atthe; Gheorghe D Mateescu; Chris A Flask; Xin Yu
Journal:  NMR Biomed       Date:  2011-12-09       Impact factor: 4.044

3.  Altered systemic ketone body metabolism in advanced heart failure.

Authors:  Ajit Janardhan; Jane Chen; Peter A Crawford
Journal:  Tex Heart Inst J       Date:  2011

4.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

5.  Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a.

Authors:  Ilka Pinz; Rong Tian; Darrell Belke; Eric Swanson; Wolfgang Dillmann; Joanne S Ingwall
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

Review 6.  Creatine and creatine analogues in hypertension and cardiovascular disease.

Authors:  Deborah L Horjus; Inge Oudman; Gert A van Montfrans; Lizzy M Brewster
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

7.  G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.

Authors:  Michele Ciccarelli; J Kurt Chuprun; Giuseppe Rengo; Erhe Gao; Zhengyu Wei; Raymond J Peroutka; Jessica I Gold; Anna Gumpert; Mai Chen; Nicholas J Otis; Gerald W Dorn; Bruno Trimarco; Guido Iaccarino; Walter J Koch
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

8.  Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.

Authors:  Sergiy M Nadtochiy; William Urciuoli; Jimmy Zhang; Xenia Schafer; Joshua Munger; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

9.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

10.  Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.

Authors:  Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak
Journal:  NMR Biomed       Date:  2020-02-17       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.